Guangdong Biolight Meditech Co Ltd (300246) - Total Liabilities
Based on the latest financial reports, Guangdong Biolight Meditech Co Ltd (300246) has total liabilities worth CN¥1.24 Billion CNY (≈ $181.61 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 300246 operating cash flow to assess how effectively this company generates cash.
Guangdong Biolight Meditech Co Ltd - Total Liabilities Trend (2008–2024)
This chart illustrates how Guangdong Biolight Meditech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Guangdong Biolight Meditech Co Ltd's assets to evaluate the company's liquid asset resilience ratio.
Guangdong Biolight Meditech Co Ltd Competitors by Total Liabilities
The table below lists competitors of Guangdong Biolight Meditech Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Yuanta Sec Kor
KO:003470
|
Korea | ₩16.98 Trillion |
|
Spearhead Integrated Marketing
SHE:300071
|
China | CN¥926.44 Million |
|
Charter Hall Social Infrastructure REIT
AU:CQE
|
Australia | AU$807.80 Million |
|
Troax Group AB
ST:TROAX
|
Sweden | Skr220.93 Million |
|
Jiangsu Kuangshun Photosensitivity New-Material Stock Co Ltd
SHE:300537
|
China | CN¥420.20 Million |
|
Thai Vegetable Oil Public Company Limited
BK:TVO
|
Thailand | ฿3.48 Billion |
|
PetroVietnam Fertilizer and Chemicals Corp
VN:DPM
|
Vietnam | ₫6.24 Trillion |
Liability Composition Analysis (2008–2024)
This chart breaks down Guangdong Biolight Meditech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Guangdong Biolight Meditech Co Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.62 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.02 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.49 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangdong Biolight Meditech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangdong Biolight Meditech Co Ltd (2008–2024)
The table below shows the annual total liabilities of Guangdong Biolight Meditech Co Ltd from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.21 Billion ≈ $176.73 Million |
+5.44% |
| 2023-12-31 | CN¥1.15 Billion ≈ $167.62 Million |
+22.32% |
| 2022-12-31 | CN¥936.42 Million ≈ $137.03 Million |
+28.78% |
| 2021-12-31 | CN¥727.13 Million ≈ $106.40 Million |
+26.60% |
| 2020-12-31 | CN¥574.33 Million ≈ $84.04 Million |
+52.90% |
| 2019-12-31 | CN¥375.62 Million ≈ $54.96 Million |
+26.91% |
| 2018-12-31 | CN¥295.97 Million ≈ $43.31 Million |
+20.24% |
| 2017-12-31 | CN¥246.15 Million ≈ $36.02 Million |
+35.03% |
| 2016-12-31 | CN¥182.29 Million ≈ $26.68 Million |
+52.19% |
| 2015-12-31 | CN¥119.78 Million ≈ $17.53 Million |
+31.53% |
| 2014-12-31 | CN¥91.07 Million ≈ $13.33 Million |
+16.99% |
| 2013-12-31 | CN¥77.84 Million ≈ $11.39 Million |
+40.08% |
| 2012-12-31 | CN¥55.57 Million ≈ $8.13 Million |
+31.79% |
| 2011-12-31 | CN¥42.16 Million ≈ $6.17 Million |
+10.73% |
| 2010-12-31 | CN¥38.08 Million ≈ $5.57 Million |
+4.49% |
| 2009-12-31 | CN¥36.44 Million ≈ $5.33 Million |
+14.35% |
| 2008-12-31 | CN¥31.87 Million ≈ $4.66 Million |
-- |
About Guangdong Biolight Meditech Co Ltd
Guangdong Biolight Meditech Co., Ltd. engages in the research and development, production, sale, and service of medical devices products and solutions in China. It operates in two segments, Life Information and Support, and Kidney Disease. The company offers emergency and critical care monitor, subcritical care monitor, general ward monitor, outpatient monitor, neonatal monitor, infusion pump, el… Read more